This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsoporis, J. N. Articles by Parker, T. G. Search for Related Content PubMed PubMed Citation Articles by Tsoporis, J. N. Articles by Parker, T. G. Related Collections Structure Acute myocardial infarction Hypertrophy Animal models of human disease Apoptosis Physiological and pathological control of gene expression

(Circulation. 2005;111:598-606.)
© 2005 American Heart Association, Inc.

Heart Failure

S100B Expression Modulates Left Ventricular Remodeling After Myocardial Infarction in Mice

James N. Tsoporis, PhD; Alexander Marks, MD; Abraham Haddad, MSc; Fayez Dawood, DVM; Peter P. Liu, MD; Thomas G. Parker, MD

From the Division of Cardiology, St Michael’s Hospital (J.N.T., A.H., T.G.P.), and Banting and Best Department of Medical Research (A.M.), Heart and Stroke/Richard Lewar Centre of Excellence (F.D., P.P.L.), University of Toronto, Toronto, Canada.

Reprint requests to Thomas G. Parker, Division of Cardiology, St Michael’s Hospital, 30 Bond St, Queen Wing, Room 6-044, Toronto, Ontario M5B 1W8, Canada. E-mail parkertg{at}smh.toronto.on.ca

Received June 14, 2004; revision received September 30, 2004; accepted October 22, 2004.

Background— S100B, a 20-kDa, Ca²⁺-binding dimer, is a putative intrinsic negative regulator of myocardial hypertrophy expressed after myocardial infarction. S100B-overexpressing transgenic (TG) and S100B-knockout (KO) mice have been generated to assess the consequences of S100B expression and altered hypertrophy after infarction.

Methods and Results— We compared 21 wild-type (WT), 20 TG, and 24 KO mice over 35 days after experimental myocardial infarction with sham-operated controls (n=56). Of those, 4 WT-infarcted mice, 7 TG-infarcted mice, and 1 KO-infarcted mouse and no sham-operated mice died during the observation period. Among survivors, echocardiography, hemodynamic studies, and postmortem examination indicated that the WT and KO groups of infarcted mice mounted a hypertrophic response that was augmented in KO mice. The S100B-overexpressing TG group did not develop hypertrophy but demonstrated increased apoptosis. The postinfarct end-diastolic pressure was lower in KO mice than in WT mice, in accordance with other structural, hemodynamic, and functional parameters, which suggests that abrogation of S100B expression augmented hypertrophy, decreased apoptosis, and was beneficial to preservation of cardiac function within this time frame.

Conclusions— S100B regulates the hypertrophic response and remodeling in the early postinfarct period and represents a potential novel therapeutic target.

Key Words: hypertrophy • proteins • myocardial infarction • apoptosis • remodeling

This article has been cited by other articles:

				L. G. Bucciarelli, R. Ananthakrishnan, Y. C. Hwang, M. Kaneko, F. Song, D. R. Sell, C. Strauch, V. M. Monnier, S. F. Yan, A. M. Schmidt, et al. RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium Diabetes, July 1, 2008; 57(7): 1941 - 1951. [Abstract] [Full Text] [PDF]

				R. Ramasamy, S. F. Yan, and A. M. Schmidt Stopping the Primal RAGE Reaction in Myocardial Infarction: Capturing Adaptive Responses to Heal the Heart? Circulation, June 24, 2008; 117(25): 3165 - 3167. [Full Text] [PDF]

				S. T. Pleger, P. Most, and H. A. Katus S100 proteins: A missing piece in the puzzle of heart failure? Cardiovasc Res, July 1, 2007; 75(1): 1 - 2. [Full Text] [PDF]

				M. Odashima, S. Usui, H. Takagi, C. Hong, J. Liu, M. Yokota, and J. Sadoshima Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction Circ. Res., May 11, 2007; 100(9): 1344 - 1352. [Abstract] [Full Text] [PDF]

				P. Most, H. Seifert, E. Gao, H. Funakoshi, M. Volkers, J. Heierhorst, A. Remppis, S. T. Pleger, B. R. DeGeorge Jr, A. D. Eckhart, et al. Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction Circulation, September 19, 2006; 114(12): 1258 - 1268. [Abstract] [Full Text] [PDF]